Cargando…
Clinical impact of molecular breast imaging as adjunct diagnostic modality in evaluation of indeterminate breast abnormalities and unresolved diagnostic concerns
Improvements in molecular breast imaging (MBI) have increased the use of MBI as adjunct diagnostic modality and alternative to MRI. We aimed to assess the value of MBI in patients with equivocal breast lesions on conventional imaging, especially in terms of its ability to rule out malignancy. METHOD...
Autores principales: | van Loevezijn, Ariane A., Corion, Christinne L.S., Zeillemaker, Anneke M., Wijers, Lidy M.H., Smithuis, Robin H.M., Valdés Olmos, Renato A., van der Hage, Jos A., de Geus-Oei, Lioe-Fee, Benard, Menno, Pereira Arias-Bouda, Lenka M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171295/ https://www.ncbi.nlm.nih.gov/pubmed/36897051 http://dx.doi.org/10.1097/MNM.0000000000001684 |
Ejemplares similares
-
The clinical impact of molecular breast imaging in women with proven invasive breast cancer scheduled for breast-conserving surgery
por: Collarino, Angela, et al.
Publicado: (2018) -
The current role of nuclear medicine in breast cancer
por: Vaz, Sofia C., et al.
Publicado: (2023) -
Diagnostics in Patients Suspect for Breast Cancer in The Netherlands
por: Voets, Madelon M., et al.
Publicado: (2021) -
FDG-PET/CT in indeterminate thyroid nodules: cost-utility analysis alongside a randomised controlled trial
por: de Koster, Elizabeth J., et al.
Publicado: (2022) -
PET/CT in Patients with Breast Cancer Treated with Immunotherapy
por: Vaz, Sofia C., et al.
Publicado: (2023)